Publications
122
Citations
3,889
Est. group size
—
Recurring co-author estimate
Active years
46
Publishing since 1981
Yoshinobu Koguchi studies how the immune system responds to cancer, focusing on cancer immunotherapy in tumors such as head and neck, lung, kidney, and breast cancer. Their work examines immune checkpoint therapies (like anti-PD-1, anti-LAG-3, and anti-GITR), cancer vaccines, and T cell behavior within tumors, using tools such as multi-omics profiling, mass spectrometry, and single-cell sequencing to identify biomarkers and immune targets that could improve treatment outcomes.
Publication output has grown over the past decade, rising from around 3-7 papers per year in 2017-2021 to a higher and more variable pace of 5-13 papers per year in 2022-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)
OncoImmunology · 2026
- Abstract LB425: Search for targets of anti-cancer immunity in patients receiving an off-the-shelf cancer’s dark matter vaccine, DPV-001, combined with anti-PD-1 +/- anti-GITR in head and neck squamous cell cancer (HNSCC)
Cancer Research · 2026
- The response to anti–PD-1 and anti–LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming
Science Translational Medicine · 2025
- INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering
Journal for ImmunoTherapy of Cancer · 2025
- Identification of a TCR to a non-canonical peptide (NCP) presented by the autologous non-small cell lung cancer (NSCLC) following an immunotherapy that includes canonical and NCPs 3338
The Journal of Immunology · 2025
- 832 Integrative multi-omics analysis reveals enrichment of exhausted CD8 <sup>+</sup> and CD4 <sup>+</sup> CD8 <sup>+</sup> T cells in the renal cell carcinoma tumor microenvironment
Regular and Young Investigator Award Abstracts · 2025
- 163 Unveiling the non-canonical dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC) using mass spectrometry and watchmaker total RNA-Seq
Regular and Young Investigator Award Abstracts · 2025
- 636 Addition of GITR agonist to a dark matter cancer vaccine and anti-PD-1 increases regulatory T cell numbers without appearing to impact therapeutic efficacy
Regular and Young Investigator Award Abstracts · 2025
- Phenotypic and clonal evolution of CD4 T cells in HNSCC during immunotherapy: a case report 3277
The Journal of Immunology · 2025
- Differentiation of neoantigen-reactive CD8 T cells in tumors from patients with mismatch repair-proficient colorectal cancers 4297
The Journal of Immunology · 2025
- Multi-cancer comparative multi-omics approach reveals a permissive tumor microenvironment in renal cell carcinoma through accumulation of exhausted CD8+ and CD4+CD8+ double positive T cells 2661
The Journal of Immunology · 2025
- Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites
Journal for ImmunoTherapy of Cancer · 2024
- Abstract CT112: An off-the-shelf multivalent vaccine containing cancer’s dark matter, DPV-001, combined with PD-1 +/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial
Cancer Research · 2024
- 1481 Off-the-shelf dark matter immunotherapy in head & neck cancer: mechanistic insights and clinical efficacy
2024
- 152 Detection of PIK3CA mutation-derived neoepitopes from cancer cell lines
Regular and Young Investigator Award Abstracts · 2024
- Regular and Young Investigator Award Abstracts×18
- Journal for ImmunoTherapy of Cancer×9
- The Journal of Immunology×9
- Cancer Research×6
- Journal of Clinical Oncology×5
- Andreas Wieland
Medicine · The Ohio State University
- Tarah J. Ballinger
Medicine · Indiana University
- Nandini Acharya
Medicine · The Ohio State University
- Hazem E. Ghoneim
Medicine · The Ohio State University
- No‐Joon Song
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile